| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
41,560,000 |
| Market
Cap: |
436.38(M) |
| Last
Volume: |
5,200 |
Avg
Vol: |
5,158 |
| 52
Week Range: |
$7.24 - $20.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
30,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$188,940 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
73,956 |
94,067 |
94,067 |
224,649 |
| Total Sell Value |
$802,050 |
$1,166,593 |
$1,166,593 |
$2,241,301 |
| Total People Sold |
7 |
8 |
8 |
13 |
| Total Sell Transactions |
9 |
11 |
11 |
18 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tyndall Joseph A. |
Director |
– • – |
2025-06-10 |
4 |
S |
$10.72 |
$288,700 |
D/D |
(26,931) |
0 |
|
2% |
|
| Tyndall Joseph A. |
Director |
– • – |
2025-06-10 |
4 |
OE |
$6.30 |
$75,952 |
D/D |
11,586 |
26,931 |
|
- |
|
| Weiler Kathy Johnson |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
6,580 |
|
-1% |
|
| Johnson John H |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
24,943 |
|
-1% |
|
| Levine Alan M |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
36,743 |
|
-1% |
|
| Neels Guido J |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
86,743 |
|
-1% |
|
| Burke Willaim P |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
24,484 |
|
-1% |
|
| Wendell Amy Mcbride |
Director |
– • – |
2025-06-09 |
4 |
S |
$10.61 |
$43,215 |
D/D |
(4,073) |
93,826 |
|
-1% |
|
| Tyndall Joseph A. |
Director |
– • – |
2025-05-22 |
4 |
S |
$11.20 |
$224,694 |
D/D |
(20,062) |
15,345 |
|
4% |
|
| Tyndall Joseph A. |
Director |
– • – |
2025-05-22 |
4 |
OE |
$6.30 |
$80,955 |
D/D |
12,850 |
35,407 |
|
- |
|
| Tyndall Joseph A. |
Director |
– • – |
2025-05-19 |
4 |
S |
$11.63 |
$29,366 |
D/D |
(2,525) |
22,557 |
|
11% |
|
| Hartley Lindsey Marie |
CFOOfficer |
• – – |
2025-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,763 |
|
-8% |
|
| Devinney Erick Wayne |
Chief Innovation Officer |
• – – |
2025-03-19 |
4 |
S |
$17.50 |
$264,443 |
D/D |
(15,111) |
217,762 |
|
41% |
|
| Devinney Erick Wayne |
Chief Innovation Officer |
• – – |
2025-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,462 |
232,873 |
|
- |
|
| Kemp Jens |
Chief Marketing Officer |
• – – |
2025-03-04 |
4 |
D |
$18.36 |
$73,495 |
D/D |
(4,003) |
27,683 |
|
- |
|
| Began Marc A |
EVP & General Counsel |
• – – |
2025-03-04 |
4 |
D |
$18.36 |
$108,342 |
D/D |
(5,901) |
18,285 |
|
- |
|
| Devinney Erick Wayne |
Chief Innovation Officer |
• – – |
2025-03-04 |
4 |
D |
$18.35 |
$152,232 |
D/D |
(8,296) |
201,005 |
|
- |
|
| Wendell Amy Mcbride |
Director |
– • – |
2025-03-03 |
4 |
AS |
$20.02 |
$100,100 |
D/D |
(5,000) |
97,899 |
|
-46% |
|
| Began Marc A |
EVP & General Counsel |
• – – |
2025-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,500 |
24,186 |
|
- |
|
| Devinney Erick Wayne |
Chief Innovation Officer |
• – – |
2025-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,799 |
209,301 |
|
- |
|
| Kemp Jens |
Chief Marketing Officer |
• – – |
2025-02-25 |
4/A |
D |
$16.49 |
$13,423 |
D/D |
(814) |
31,686 |
|
- |
|
| Devinney Erick Wayne |
Chief Innovation Officer |
• – – |
2025-02-25 |
4 |
D |
$16.50 |
$16,038 |
D/D |
(972) |
184,502 |
|
- |
|
| Kemp Jens |
Chief Marketing Officer |
• – – |
2025-02-25 |
4 |
D |
$16.49 |
$13,423 |
D/D |
(814) |
1,686 |
|
- |
|
| Began Marc A |
EVP & General Counsel |
• – – |
2025-02-25 |
4 |
D |
$16.50 |
$13,431 |
D/D |
(814) |
1,686 |
|
- |
|
| Kemp Jens |
Chief Marketing Officer |
• – – |
2025-02-22 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
32,500 |
|
- |
|
492 Records found
|
|
Page 1 of 20 |
|
|
0.03 (0.29%) 
